[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342225-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342225-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","patterns-of-care-for-vulvar-cancer-and-insights-from-revised-figo-staging-a-retrospective-study","Patterns of care for vulvar cancer and insights from revised FIGO staging - a retrospective study","","Retrospective analysis of women with biopsy-proven vulvar malignancy assessed clinicopathological features and real-world patterns of care at a tertiary teaching institute, and evaluated implications of the revised FIGO staging on stage migration and patient outcomes. FIGO assignment was compared using 2009 and 2021 systems. Survival was estimated with Kaplan-Meier methods and tested via log-rank; multivariable Cox models were used. Of 82 cases, treatment varied widely, with surgery predominating and measurable stage shifts under FIGO 2021.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/patterns-of-care-for-vulvar-cancer-and-insights-from-revised-figo-staging-a-retrospective-study/342225/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/patterns-of-care-for-vulvar-cancer-and-insights-from-revised-figo-staging-a-retrospective-study/342225.png","ImageObject",300,407,{"name":42,"@type":43},"Genevieve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the retrospective study on vulvar cancer?","Question",{"text":63,"@type":64},"The study evaluated clinicopathological characteristics and patterns of care in women with vulvar malignancy, and analyzed how the revised FIGO staging system affected stage shift and patient outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were FIGO stages assigned and compared in the study?",{"text":68,"@type":64},"FIGO staging was assigned using both the 2009 and 2021 FIGO staging systems for comparative analysis, based on reviewed hospital records over 10 years.",{"name":70,"@type":61,"acceptedAnswer":71},"What treatment patterns and survival outcomes were reported among the 82 enrolled cases?",{"text":72,"@type":64},"Most patients underwent surgery (73.2%), followed by definitive radiotherapy (10.9%) and neoadjuvant radiotherapy followed by surgery (4.9%), with palliative care in 10.9%. Median disease-free survival was 17 months and overall survival was 27 months.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342225,1790161781,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":118,"preview_page_count":33,"preview_urls":145},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Singhal etal. World Journal of Surgical Oncology (2024) 22:329  \n[https://doi.org/10.1186/s12957-024-03612-1](https://doi.org/10.1186/s12957-024-03612-1)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nPatterns of care for vulvar cancer and insights  from revised FIGO staging: a retrospective study  \nSeema Singhal 1, Daya Nand Sharma2, Sandeep Mathur3, SwatiTomar 1, Jyoti Meena 1, Anju Singh 1 and Neerja Bhatla 1*  \nAbstract  \nBackground The objective of this study was to evaluate the clinicopathological characteristics and patterns of care among women diagnosed with vulvar malignancy at a tertiary care teaching institute. Additionally, the study aimed to analyse the implications of revised FIGO staging system on stage shift and patient outcomes.  \nMethods A retrospective observational study was conducted, wherein hospital records of biopsy-proven cases of vulvar cancers managed over a period of 10 years were comprehensively reviewed. The assignment of FIGO staging was performed utilizing both 2009 and 2021 FIGO staging systems for comparative analysis. Statistical analysis was performed using STATA version 17. Survival curves were constructed using the Kaplan-Meier method, with differences assessed using the log-rank test. Additionally, multivariable analysis was conducted using the Cox proportional hazard model.  \nResults A total of 82 cases meeting the inclusion criteria were enrolled in the study. Management patterns  \nvaried widely, with the majority undergoing surgery (73 . 2%), followed by definitive radiotherapy with or without chemotherapy (10 . 9%), neoadjuvant radiotherapy and subsequent surgery (4 . 9%), and palliative care (10 . 9%) . Postoperative radiotherapy was administered in 31. 7% of cases. The disease-specific recurrence rate was found to be 32. 9%, and the mortality rate was 30. 5% . The median Disease-Free Survival (DFS) was 17 months (interquartile range [IQR]: 1–36 months), while the Overall Survival (OS) was 27 months (IQR: 9–52 months) . Upon application of the 2021 staging system, a stage shift was observed in 18% of cases of advanced vulvar cancer. The 3-year DFS and OS were reduced for stage IIIA and stage IVA, while showing improvement for stage IIIB.  \nConclusions The revised FIGO 2021 staging system offers enhanced simplicity in its application within clinical practice and demonstrates improved correlation with prognosis. Approximately 18% cases experienced restaging under the updated system.  \nTrial registration number Not applicable.  \nKeywords Carcinoma vulva, Disease free survival, FIGO 2021 staging, Patterns of treatment, Overall survival  \n*Correspondence:  \nNeerja Bhatla  \n[neerja.bhatla07@gmail.com](neerja.bhatla07@gmail.com)  \n1Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India  \n2Department of Radiation Oncology, Dr BAIRCH All India Institute of Medical Sciences, New Delhi, India  \n3Department of Pathology, All India Institute of Medical Sciences, New Delhi, India  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of t","cbCaiceEXLMdbpvr","https://ap.wps.com/l/cbCaiceEXLMdbpvr","pdf",1600303,"English","# Background\n# Methods\n# Results\n## Treatment patterns and outcomes\n# Conclusions","[{\"question\":\"What was the main objective of the retrospective study on vulvar cancer?\",\"answer\":\"The study evaluated clinicopathological characteristics and patterns of care in women with vulvar malignancy, and analyzed how the revised FIGO staging system affected stage shift and patient outcomes.\"},{\"question\":\"How were FIGO stages assigned and compared in the study?\",\"answer\":\"FIGO staging was assigned using both the 2009 and 2021 FIGO staging systems for comparative analysis, based on reviewed hospital records over 10 years.\"},{\"question\":\"What treatment patterns and survival outcomes were reported among the 82 enrolled cases?\",\"answer\":\"Most patients underwent surgery (73.2%), followed by definitive radiotherapy (10.9%) and neoadjuvant radiotherapy followed by surgery (4.9%), with palliative care in 10.9%. Median disease-free survival was 17 months and overall survival was 27 months.\"}]","Patterns of care for vulvar cancer and insights from revised FIGO staging - a retrospective study | PDF",1790045848,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65cfd92f429a05ea9a227fa474931e5a.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44e29a817289b8dd4f7c8dece3aee0c9.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6cf73df508d47072c8cb578725457d1.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75571572e3b99c3787a63c674d32f622.webp",980,1306]